Join to View Full Profile
20 Prospect AveHackensack, NJ 07601
Phone+1 551-996-2608
Fax+1 551-996-0826
Dr. Hartono is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Choli Hartono is a nephrologist in Hackensack, NJ. He received his medical degree from Boston University School of Medicine and has been in practice 23 years. He specializes in kidney & pancreas transplantation and is experienced in rejection, transplant nephrology, healthcare outcomes research, graft survival, and immunosuppressive agents. He has more than 50 publications and over 500 citings.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Nephrology, 1997 - 2000
Graduate HospitalResidency, Internal Medicine, 1994 - 1997
Boston University School of MedicineClass of 1994
Certifications & Licensure
NY State Medical License 1998 - 2026
NJ State Medical License 2024 - 2025
MA State Medical License 2006 - 2011
PA State Medical License 1995 - 1998
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Fellow (ASNF) American Society of Nephrology
Publications & Presentations
PubMed
- Immunosuppression withdrawal in living-donor renal transplant recipients following induction with antithymocyte globulin and rituximab: Results of a prospective clinic...James F Markmann, Bryna E Burrell, Jonathan S Bromberg, Choli Hartono, Dixon B Kaufman
American Journal of Transplantation. 2024-07-01 - Complications of rabbit anti-thymocyte globulin induction immunosuppression in HIV-infected kidney transplant recipients.Ayman Al Jurdi, Esther C Liu, Thalia Salinas, Meredith J Aull, Michelle Lubetzky
Frontiers in Nephrology. 2022-01-01 - 8 citationsCasirivimab-Imdevimab (REGN-COV2) for Mild to Moderate SARS-CoV-2 Infection in Kidney Transplant Recipients.Esther C Liu, Jennifer H. Lee, Angela Loo, Shawn Mazur, Samuel Sultan
Kidney International Reports. 2021-09-06
Journal Articles
- Immunosuppression Withdrawal in Living-donor Renal Transplant Recipients Following Induction with Anti-thymocyte Globulin and Rituximab: Results of a Prospective Clini...James F Markmann, Bryna E Burrell, Jonathan S Bromberg, Choli Hartono, Dixon B Kaufman, Andrew M Possselt, Ali Naji, Nancy D Bridges, Cynthia Breeden, Sai Kanaparthi, ..., AmJTransplant. 2024 Mar 9:S1600-6135, 3/9/2024
- Kidney Allograft Failure in the Steroid‐Free Immunosuppression Era: A Matched Case‐Control StudyJoseph E Schwartz, Jun B Lee, Choli Hartono, John R Lee, Darshana M Dadhania, Sandip Kapur, Meredith J Aull, Surya V Seshan, Manikkam Suthanthiran, Mohamad M Alkadi, A..., Clinical Transplantation
Professional Memberships
- Fellow
- American Society of TransplantationMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
